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Introduction: Preeclampsia is a pregnancy-specific complication that significantly contributes 
to maternal and perinatal morbidity and mortality worldwide, even more so in developing 
countries such as Nepal. The potential contribution of dyslipidemia and elevated levels of 
oxidized low-density lipoprotein (oxLDL) in the pathogenesis of preeclamptic pregnancies 
has been observed in several studies. The aim of this study was to compare the maternal lipid 
profile parameters and particularly oxLDL between preeclamptic and healthy pregnancies and 
also correlate oxLDL with other lipid profile parameters.
Patients and methods: A total of 54 preeclamptic women were selected as cases for this 
cross-sectional study. Age and gestational week-matched 60 pregnant women were enrolled as 
controls. Preeclampsia was defined as per Australasian Society Consensus Statement research 
definition. The serum lipid parameters were measured using automated enzymatic systems and a 
competitive enzyme-linked immunosorbent assay was used to determine oxLDL concentrations 
in the serum. Student’s t-test was used to compare oxLDL levels between preeclamptic and 
healthy pregnancies, and Pearson’s correlation analysis was carried out to assess the relation 
between oxLDL and other variables.
Results: The mean values of serum total cholesterol, triglyceride, non-high-density lipoprotein-
cholesterol (non-HDL-c) and oxLDL were significantly higher in the preeclamptic cases 
(P,0.01). However, the levels of low-density lipoprotein cholesterol (LDL-c and HDL-c) did 
not significantly differ between the two groups. oxLDL had a significant positive correlation 
(P,0.01) with total cholesterol, triglyceride, LDL-c and non-HDL-c, and a negative correlation 
with HDL-c.
Conclusion: The atherogenic type of dyslipidemia and high oxLDL levels are associated with 
preeclamptic pregnancies. The lipid parameters, however, seem to be poor markers of the severity 
of preeclampsia. Further prospective studies are needed to see if the observed dyslipidemia has 
a causal role in preeclampsia and imparts a long-term cardiovascular risk.
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Introduction
Preeclampsia is a pregnancy-specific complication characterized by an onset of 
hypertension, proteinuria, and edema, occurring in the late second trimester (after 
20 weeks of gestation). It complicates 5%–6% of all pregnancies and remains a major 
cause of maternal and perinatal morbidity and mortality worldwide.1 The incidence 
of hypertensive disorders along with the maternal mortality rates and preterm births 
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related to preeclampsia in the developing countries is higher 
than those reported in developed countries.2 In Nepal, the 
incidence of preeclampsia or eclampsia was 20 cases to 1,000 
hospital deliveries.3
The upregulation of antiangiogenic factors in the placenta 
(leading to poor placentation) along with maternal endothelial 
dysfunction is considered to be one of the most plausible 
explanations for the pathogenesis and clinical manifestations 
of preeclampsia.4 There is also a well-established relation 
between preeclampsia and increased oxidative stress due 
to endothelial dysfunction, which in turn is potentially 
contributed by the abnormal lipid profile present in these 
women.5 The oxidized low-density lipoprotein (oxLDL) 
results from one of the biologically relevant modifications 
in LDL in the form of oxidation. The link between oxLDL 
and cardiovascular diseases has been well established, and 
interests have developed in finding its association with the 
pathogenesis of preeclampsia. Dyslipidemia has been found 
to be one of the strongest predictors of levels of oxLDL in 
middle-aged adults,6 and the effect seems to be amplified in 
pregnant women with preeclampsia, where the dyslipidemia 
is even more pronounced.5
The aim of this study was to compare the maternal lipid 
profile parameters, particularly oxLDL, between preeclamp-
tic and healthy pregnancies and also correlate oxLDL with 
other lipid parameters.
Material and methods
This cross-sectional case–control study was conducted in Insti-
tute of Medicine, Tribhuvan University Teaching Hospital, 
Nepal. The tertiary care hospital is situated at approximately 
1,400 m (4,600 ft) above the sea level. A total of 54 preec-
lamptic women (cases) and 60 pregnant women (controls) 
were enrolled after the written informed consent and ethical 
approval from the Institutional Review Board of Institute of 
Medicine. Preeclampsia was defined as new onset of hyperten-
sion after 20 weeks of gestation with proteinuria; hypertension 
was defined as systolic blood pressure $140 mmHg and/or 
diastolic blood pressure $90 mmHg, and proteinuria was 
considered to be present if the 24-hour urinary total protein 
excretion was $300 mg/24 hours. The preeclamptic cases 
were categorized as “severe” if severe hypertension was asso-
ciated with proteinuria or if hypertension was associated with 
severe proteinuria. The criteria for severe hypertension and 
severe proteinuria were, respectively: 1) systolic blood pres-
sure $160 mmHg or diastolic blood pressure $110 mmHg 
and 2) proteinuria .5 g/24-hour as per Australasian Society 
Consensus Statement research definition.7 The preeclamptic 
cases not meeting the aforementioned criteria were catego-
rized as “mild”. Primigravid women diagnosed to have preec-
lampsia were explained about the study and were enrolled 
from the maternity ward of the hospital. Age and gestational 
week-matched pregnant controls were selected from women 
who visited antenatal checkup clinic.
Serum and urine samples from the cases were collected 
within 24 hours of diagnosis. In all patients, blood samples 
were obtained by trained phlebotomist from the most 
accessible vein taking aseptic precautions and then placed 
in ethylenediaminetetraacetic acid-containing vials. Blood 
samples were centrifuged at 4,000 rpm for 5 minutes at room 
temperature and the separated serum was stored at -40°C 
until the assays were performed.
The concentrations of the serum lipids (total cholesterol 
[TC], high-density lipoprotein cholesterol [HDL-c], and 
triglycerides [TG]) were assayed using automated system 
(Biotecnica Chemistry Analyzer 3000, Italy) with standard 
enzymatic assays. LDL-c was calculated using Friedewald’s 
formula. A competitive enzyme-linked immunosorbent assay 
(OxLDL ELISA kit, Bio-Ekon, Beijing, People’s Republic 
of China) was used to determine oxLDL concentrations 
in the serum.
Data analyses included standard descriptive statistics using 
SPSS version 20 (IBM Corporation, Armonk, NY, USA), 
with variables expressed as mean ± standard deviation or 
medians and range as appropriate. Shapiro–Wilk test was used 
to test the normality in the distribution of variables. Unpaired 
Student’s t-test was used for comparison of means between 
groups for normally distributed variables and Mann–Whitney 
U-test for comparison of variables that did not follow normal 
distribution. Pearson’s correlation analysis was performed to 
examine the association between oxLDL and other variables. 
A P-value of ,0.05 was considered statistically significant.
Results
The case and control groups were not statistically different 
in age and weeks of gestation. The levels (mean values) 
of TC, TG, non-HDL-c, and oxLDL were significantly 
higher in the preeclamptic cases than in pregnant controls. 
However, the levels of low-density lipoprotein cholesterol 
(LDL-c) and HDL-c did not significantly differ between the 
two groups (Table 1).
There was no statistically significant difference in the 
various lipid parameters while comparing mild and severe 
preeclampsia cases, except for LDL-c and non-HDL-c 
(Table 2). The mean values of these two parameters were 
significantly higher in the severe preeclamptic cases.
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There was no correlation of oxLDL with age and gesta-
tional period. Table 3 shows the correlation of ox-LDL with 
other parameters of the lipid profile when all the subjects 
were considered. A significant positive correlation (P,0.00) 
between oxLDL and TC, LDL-c, TG, and non-HDL-c was 
observed (Table 3). OxLDL was negatively correlated 
with HDL-c (Pearson’s r=-0.06), although not statistically 
significant.
Discussion
Preeclampsia is a pregnancy-specific condition with evident 
lipid alterations, somewhat exaggerated than the “physi-
ological” dyslipidemia that occurs in the normal pregnant 
women. In the current study, significantly higher concen-
trations of serum TC, TG, and non-HDL-c were found in 
the preeclamptic cases compared to pregnant controls. The 
hypertriglyceridemia along with increase in TC and LDL-c 
observed in this study is in agreement with other studies.8,9 
A few studies, however, are not in complete agreement 
with this.10,11
The role of high-serum TG in the pathogenesis of preec-
lampsia is a subject of controversy. Earlier studies have 
hypothesized that hypertriglyceridemia, in preeclampsia, may 
lead to increased endothelial TG accumulation and generation 
of small, dense LDL particles, contributing to the endothelial 
dysfunction.12 The high levels of serum TG in preeclamptic 
women are believed to be due to high circulating levels 
of apolipoprotein E that interfere with TG clearance by 
interfering with lipoprotein lipase activator, apolipoprotein 
C-II.11 Although elevated TG levels are consistent with 
preeclamptic cases, no direct relationship has been observed 
between the TG levels and severity of preeclampsia,13 also 
evidenced from our study.
Except for the LDL-c and non-HDL-c values, the rest of 
the lipid parameters were not significantly different between 
mild and severe preeclampsia. It can be concluded from this 
study and other studies that the lipid parameters seem to be 
poor markers of the severity of preeclampsia. Though a rise 
in LDL-c and a decrease in HDL-c levels were observed 
in preeclamptic women in this study, the difference with 
normal pregnant women did not reach statistical significance. 
Significant changes in LDL-c and HDL-c levels in preeclamp-
tic women have been increasingly suggested as important risk 
factors for the development of atherosclerosis.14
Belo et al observed higher mean serum TG concentrations 
and lower HDL-c concentrations with an increased propor-
tion of atherogenic small dense LDL in the preeclamptic 
women in the third trimester compared with healthy pregnant 
women.5 Therefore, the physiological “atherogenic” lipid 
profile in normal pregnancy has been observed to be enhanced 
in preeclampsia. However, whether, this dyslipidemia is a 
“cause” or “effect” of endothelial dysfunction, still remains 
to be answered. Enquobahrie et al concluded that early 
pregnancy dyslipidemia, especially increased levels of serum 
TG and serum LDL-c, is associated with an increased risk 
Table 1 age, weeks of gestation, and serum lipid levels in the 
study subjects (mean ± sD)
Variables Pregnant  
controls (n=60)
Pregnant  
cases (n=54)
P-value
age (years) 26.13±3.36 26.41±3.23 ns
Weeks of gestation 31.22±2.93 32.02±3.08 ns
Tc (mmol/l) 5.56±0.65 6.03±0.97 ,0.001
lDl-c (mmol/l) 3.11±0.78 3.44±1.13 ns
Tg (mmol/l) 2.46±0.40 3.07±0.46 ,0.001
HDl-c (mmol/l) 1.33±0.36 1.19±0.41 ns
non-HDl-c (mmol/l) 4.23±0.77 4.83±1.13 ,0.001
oxlDl (U/l) 20.30±8.40 55.79±28.85 ,0.001
Abbreviations: HDl-c, high density lipoprotein cholesterol; lDl-c, low-density 
lipoprotein cholesterol; NS, not statistically significant; oxLDL, oxidized low-density 
lipoprotein; sD, standard deviation; Tc, total cholesterol; Tg, triglyceride.
Table 2 age, weeks of gestation, and serum lipid levels in mild vs 
severe preeclampsia cases (mean ± sD or median [range])
Parameters Mild  
preeclampsia  
(n=41)
Severe  
preeclampsia  
(n=13)
P-value
age (years) 26.24±3.07 26.92±3.77 ns
Weeks of gestation 32.05±3.29 31.92±2.40 ns
Tc (mmol/l) 5.90 (4.50–7.50) 6.70 (4.60–9.70) ns
lDl-c (mmol/l) 3.24±1.01 4.07±1.30 ,0.05
HDl-c (mmol/l) 1.20 (0.70–2.30) 0.90 (0.80–1.50) ns
non-HDl-c 
(mmol/l)
4.63±0.97 5.48±1.36 ,0.05
Tg (mmol/l) 2.90 (2.30–3.90) 2.90 (2.50–3.80) ns
oxlDl (U/l) 47.60 (4.20–145.80) 71.30 (8.80–138.20) ns
Abbreviations: HDl-c, high-density lipoprotein cholesterol; lDl-c, low-density 
lipoprotein cholesterol; NS, not statistically significant; oxLDL, oxidized low-density 
lipoprotein; sD, standard deviation; Tc, total cholesterol; Tg, triglyceride.
Table 3 correlation of oxlDl with other lipid parameters in the 
study subjects
Parameters Correlation  
coefficient (P-value)
Tc (mmol/l) 0.42 (0.00)
lDl-c (mmol/l) 0.33 (0.00)
Tg (mmol/l) 0.43 (0.00)
HDl-c (mmol/l) (-) 0.06 (ns)
non-HDl-c (mmol/l) 0.44 (0.00)
Abbreviations: HDl-c, high density lipoprotein cholesterol; lDl-c, low-density 
lipoprotein cholesterol; NS, not statistically significant; oxLDL, oxidized low-density 
lipoprotein; Tc, total cholesterol; Tg, triglyceride.
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of preeclampsia.8 It has therefore also been suggested that 
higher serum TG in pregnant women may warrant further 
investigation for preeclampsia.15
The contribution of oxLDL in the initiation and pro-
gression of the atherosclerotic process and its association 
with other cardiovascular diseases have been observed in 
several studies.16,17 In addition, its role in the pathogenesis 
of preeclampsia has been further sought after. In an early 
study, oxLDL was found in both villous trophoblasts and 
placental endothelium, but no significant differences were 
found in their expression intensities when placental paraffin 
sections of preeclampsia and controls were compared.10 The 
circulating levels of oxLDL depend both on the degree of 
oxidative stress and the number of LDL particles.18 Several 
studies have shown a strong positive correlation of oxLDL 
with LDL-c. One such study done on 624 cohorts demon-
strated a strong correlation between the two parameters 
(r=0.67, P,0.001) and also concluded that LDL-c is one 
of the major determinants of the oxLDL concentration.19 
In the current study, along with LDL-c, oxLDL levels also 
demonstrated a positive correlation with TC, TG, and non-
HDL-c levels (Pearson’s r ranging from 0.42–0.44, P-values 
all ,0.01). Similar findings were also evident in the study 
by Sanchez et al.20
The negative association between HDL-c and oxLDL, 
although not very strong in our study, is in accordance 
with studies elsewhere.19 The role of HDL in relation to 
oxLDL seems to be related with two of the HDL-associated 
enzymes: paraoxonase 1(PON1) and platelet-activating fac-
tor acetylhydrolase. PON1, which is exclusively located in 
HDL, contributes to the protective effect to oxidative dam-
age by causing the hydrolysis of the LDL lipid peroxides.21 
Enhanced serum levels of oxLDL have been shown to be pre-
dictive for endothelial dysfunction, with the fact that oxLDL 
itself induces vascular oxygen radical formation.22 Majority 
of atherosclerosis studies have demonstrated the relation-
ship between oxLDL and endothelial dysfunction and, the 
same might hold true in the pathogenesis of preeclampsia. 
A study by Qiu et al showed that women with elevated 
oxLDL concentrations ($50 U/L) had a 2.9-fold increased 
risk of preeclampsia when compared with women with lower 
oxLDL concentrations. The risk further increased when the 
women also had elevated TG concentrations (OR =8.9).23
Preeclampsia is a condition of dyslipidemia that could 
have possible implications for the development of cardio-
vascular diseases in later life. In fact, our study demon-
strated higher values of atherogenic lipid parameters (TC, 
TG, non-HDL-c, and oxLDL) in the preeclamptic cases 
compared with the pregnant controls. Higher oxLDL level 
in preeclampsia is not just a marker for oxidative stress 
but could also be a possible risk factor for cardiovascular 
risk in the future. Previously considered to be a disease of 
short duration (because of the resolution of symptoms after 
delivery), preeclampsia is supposed to have an effect that is 
long term. The principal underlying abnormality, endothe-
lial dysfunction, has been shown to persist in preeclamptic 
women and further contribution by the dyslipidemia (notably 
the increase in TG and LDL-c along with the decrease in 
HDL-c) influences the risk of late-life cardiovascular risk 
in these women.24 However, further prospective studies are 
needed to determine whether dyslipidemia in pregnancy, 
particularly hypertriglyceridemia and elevated LDL-c levels 
or elevated oxLDL concentrations can predict the occurrence 
of preeclampsia. Relevant studies are also needed to explore 
the relationship between this particular type of dyslipidemia 
and long-term cardiovascular risk.
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